About Goldenrod Therapeutics
Goldenrod Therapeutics is a private company based in Houston, Texas, incorporated in 2023 in Texas. It has reported $3,245,355 raised in one offering on Form D since June 2026. Its chief executive is Dev Chatterjee.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| May 26, 2026 | Jun 3, 2026 | $3,245,355of $6.5M target | 2 | $1.6M | EquityRule 506(b) | Form D ↗ |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Goldenrod Therapeutics's Form D filed Jun 3, 2026.
